SCHEMBL20009962

SCHEMBL20009962

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(ccc5cc(-c6ccc(-c7cccnc7)nc6)ccc54)c3)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 10/20 0.52
CYP11B2 P19099 9/20 0.52
CYP19A1 P11511 8/20 0.52
CYP17A1 P05093 3/20 0.52
ERN1 O75460 1/20 0.49
CYP2A6 P11509 3/20 0.49
CYP3A4 P08684 2/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
HSD17B1 P14061 1/20 0.43
CYP2B6 P20813 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSD17B2 P37059 1/20 0.43
PDGFRB P09619 2/20 0.43
PDGFRA P16234 2/20 0.43
PIM1 P11309 1/20 0.43
PIM3 Q86V86 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
GRM2 Q14416 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20009905 0.99 CYP11B1 (0.51) CYP11B1CYP11B2CYP19A1CYP17A1ERN1
SCHEMBL20010070 0.96 CYP11B1 (0.50) CYP11B1CYP11B2CYP19A1CYP17A1ERN1
SCHEMBL20010042 0.95 CYP2A6 (0.49) CYP11B1CYP11B2CYP19A1CYP17A1ERN1
SCHEMBL20010274 0.93 CYP11B2 (0.60) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6
SCHEMBL20010180 0.92 CYP11B2 (0.59) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6
SCHEMBL20010223 0.91 CYP11B2 (0.57) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6
SCHEMBL20010183 0.90 CYP11B2 (0.56) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6
SCHEMBL20010185 0.90 CYP2A6 (0.46) CYP11B1CYP11B2CYP19A1CYP17A1ERN1
SCHEMBL20009960 0.89 CYP11B2 (0.58) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6
SCHEMBL20010064 0.89 CYP2A6 (0.50) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320261-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2021-10-14 US disclosed
US-11081648-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same LG DISPLAY CO., LTD. (KR) 2021-08-03 US disclosed
US-10468605-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same LG DISPLAY CO., LTD. (KR) 2019-11-05 US disclosed
US-20180090686-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-03-29 US disclosed
US-20180090686-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180090686-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME OCIAD1, OCIAD2, AOX1 CYP11B1 1561/4885CYP11B2 1249/4885CYP19A1 1250/4885
US-20210320261-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME OCIAD1, OCIAD2, AOX1 CYP11B1 1434/4885CYP11B2 1112/4885CYP19A1 1268/4885
US-10468605-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same OCIAD1, OCIAD2, AOX1 CYP11B1 1561/4885CYP11B2 1249/4885CYP19A1 1250/4885
US-11081648-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same OCIAD1, OCIAD2, AOX1 CYP11B1 1561/4885CYP11B2 1249/4885CYP19A1 1250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.